Trial · NCT02786277
Outcomes13
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
1 to 13 of 13
Download this page as JSON| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Proportion of Patients With Progression to a Higher Stage of AKI OR Dialysis OR Death | Within 14 days from randomization | Participants | COUNT_OF_PARTICIPANTS | |
| SECONDARY | 14-day Mortality | Assessed from point of randomization to date of death within 14 days of randomization | Participants | COUNT_OF_PARTICIPANTS | |
| SECONDARY | Inpatient Mortality | Assessed from point of randomization to date of death from any cause, up to one year post-randomization | Participants | COUNT_OF_PARTICIPANTS | |
| SECONDARY | 14-day Dialysis | Assessed from point of randomization to date of first documented dialysis order, within 14 days of randomization | Participants | COUNT_OF_PARTICIPANTS | |
| SECONDARY | Inpatient Dialysis | Assess from point of randomization to date of first documented dialysis order during index hospitalization, up to one year post-randomization | Participants | COUNT_OF_PARTICIPANTS | |
| SECONDARY | Discharge on Dialysis | Assessed at point of discharge from index hospitalization, up to one year post-randomization | Participants | COUNT_OF_PARTICIPANTS | |
| SECONDARY | Progression to Stage 2 AKI | Assessed from the date of randomization to 14 days post randomization | Participants | COUNT_OF_PARTICIPANTS | |
| SECONDARY | Progression to Stage 3 AKI | Assessed from the date of randomization to 14 days post randomization | Participants | COUNT_OF_PARTICIPANTS | |
| SECONDARY | Duration of AKI | Assessed from the date of randomization to the cessation of AKI during index hospitalization, up to one year | Hours | MEDIAN | |
| SECONDARY | 30 Day Readmission Rate | Assessed from discharge date of index hospitalization to 30 days post discharge date | Participants | COUNT_OF_PARTICIPANTS | |
| SECONDARY | Index Hospitalization Cost | Assessed from point of randomization to date of discharge from index hospitalization, up to one year | The data for this outcome were not collected and will not be accessed in the future. During outcome assessment, PIs were unable to get access to financial data to assess this outcome due to lack of institutional approval, therefore, no participants were analyzed. As this is the only financial-based outcome of the trial, this is the only outcome affected by this circumstance. | ||
| SECONDARY | Chart Documentation of AKI | Assessed from date of randomization to date of discharge from index hospitalization, up to one year | Participants | COUNT_OF_PARTICIPANTS | |
| SECONDARY | Proportion of AKI Best Practices Achieved Per Subject During Index Hospitalization | 24 hours from randomization to discharge, up to one year post randomization | Proportion achieved per subject | MEDIAN |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02786277/outcomes